Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Metadata
Title
Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice
Authors
Akinori Sakai
Toshiharu Mori
Miyuki Sakuma-Zenke
Tomonori Takeda
Kenichiro Nakai
Yuji Katae
Hideyuki Hirasawa
Toshitaka Nakamura
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 1/2005
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-004-0534-y

Other articles of this Issue 1/2005

Journal of Bone and Mineral Metabolism 1/2005 Go to the issue

ORIGINAL ARTICLE

Multiple vertebral fractures are associated with refractory reflux esophagitis in postmenopausal women

ORIGINAL ARTICLE

Biomechanical impact of aluminum accumulation on the pre- and post-yield behavior of rat cortical bone

ORIGINAL ARTICLE

Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis

ORIGINAL ARTICLE

Weight gain in childhood and bone mass in female college students

ORIGINAL ARTICLE

Biphasic anti-osteoclastic action of intravenous alendronate therapy in multiple myeloma bone disease

ORIGINAL ARTICLE

Texture analysis of X-ray radiographs is correlated with bone histomorphometry

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits